New: 2026 Peptide Research Digest is live. Read the report
Research-backed content PubMed cited sources Medically reviewed by experts Quarterly content updates Research-backed content PubMed cited sources Medically reviewed by experts Quarterly content updates Research-backed content PubMed cited sources Medically reviewed by experts Quarterly content updates Research-backed content PubMed cited sources Medically reviewed by experts Quarterly content updates Research-backed content PubMed cited sources Medically reviewed by experts Quarterly content updates Research-backed content PubMed cited sources Medically reviewed by experts Quarterly content updates Research-backed content PubMed cited sources Medically reviewed by experts Quarterly content updates Research-backed content PubMed cited sources Medically reviewed by experts Quarterly content updates

Tirzepatide

Weight Loss

Dual GIP and GLP-1 Receptor Agonist

Calculate Reconstitution Read Full Data Guide

Overview Profile

A dual GIP and GLP-1 receptor agonist that acts synergistically to regulate appetite and improve metabolic function.

Primary Target Benefits

weight lossmetabolic health

Research Notice: This profile is informational. Peptides are widely sold as research chemicals and many are not FDA-approved for human consumption. Always consult local regulations and a medical provider before proceeding.

Quick Research Facts

Standard Dose Observation

2500-15000 mcg

Typical Available Vial Sizes

5mg10mg15mg30mg

Development / Research Status

FDA-Approved

More in Weight Loss

Semaglutide

GLP-1 Receptor Agonist

View Profile

AOD-9604

Advanced Obesity Drug 9604

View Profile

Retatrutide

Triple Agonist

View Profile